|Bid||272.86 x 400|
|Ask||273.19 x 200|
|Day's Range||268.38 - 273.54|
|52 Week Range||191.40 - 288.78|
|PE Ratio (TTM)||83.50|
|Earnings Date||May 3, 2018|
|Forward Dividend & Yield||1.36 (0.53%)|
|1y Target Est||285.45|
athenahealth's (ATHN) strong product portfolio, network expansion strategies and unique business model are likely to drive Q1 earnings.
Teleflex Incorporated announced today that financial results for the first quarter 2018 will be released before market open on Thursday, May 3, 2018. An investor conference call will be held at 8:00 a.m.
Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, ...
Does the share price for Teleflex Incorporated (NYSE:TFX) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. If you wantRead More...
NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results from the first analysis of a retrospective registry of more than 800 UroLift® System procedures performed at seven centers in North America, Europe and Australia.
Liam Kelly, President and CEO, Teleflex Incorporated , is scheduled to speak at Needham & Company’s 17th Annual Healthcare Conference at the Westin Grand Central Hotel in New York, NY on Tuesday, March 27, 2018 at 9:30 a.m.
Liam Kelly, President and CEO, Teleflex Incorporated , is scheduled to speak at the 28th Annual Oppenheimer Healthcare Conference at the Westin Grand Central Hotel in New York, NY on Tuesday, March 20, 2018 at 9:10 a.m.
Edwards Lifesciences (EW) is a global leader in medical innovation for structural heart disease and critical care monitoring. Edwards Lifesciences’ product pipeline is focused on the repair or replacement of the mitral and tricuspid valves of the heart. Of the 22 analysts covering Edwards Lifesciences in February 2018, 17 analysts have given the stock a “buy” or a higher rating, while four analysts have given it a “hold” rating.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding TFX totaled $233 million.
Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated , is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami, Florida, on Tuesday, March 13, 2018 at 1:35 pm .
It’s earnings season, and a steady stream of financial figures are separating the flawed from the flourishing in the pharmaceutical sector. The Ratings Leerink reiterated Outperform ratings on the following ...
The Wayne, Pennsylvania-based company said it had a loss of 91 cents per share. Earnings, adjusted for one-time gains and costs, came to $2.44 per share. The results exceeded Wall Street expectations. ...
Teleflex Incorporated announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock. The dividend is payable March 15, 2018 to shareholders of record at the close of business on March 2, 2018.
Teleflex Incorporated today announced financial results for the fourth quarter and full year ended December 31, 2017.
Teleflex Incorporated , a leading global provider of medical devices, has announced that newly published research, in the February 2018 edition of the British Journal of